• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2101233 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) New Drug Application 2021-08-03 Sichuan Baili Pharmaceutical Co Ltd view
CXSL2101461 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) New Drug Application 2021-12-06 Sichuan Baili Pharmaceutical Co Ltd view
CXSB2400051 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) Supplementary Application 2024-05-29 view
CXSL2101511 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) New Drug Application 2021-12-27 Sichuan Baili Pharmaceutical Co Ltd view
CXSL2101084 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) New Drug Application 2021-05-18 Sichuan Baili Pharmaceutical Co Ltd view
CXSL2101083 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) New Drug Application 2021-05-19 Sichuan Baili Pharmaceutical Co Ltd view
CXSL2101232 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) New Drug Application 2021-08-03 Sichuan Baili Pharmaceutical Co Ltd view
CXSL2400182 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) New Drug Application 2024-03-14 view
CXSL2101086 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) New Drug Application 2021-05-19 Sichuan Baili Pharmaceutical Co Ltd view
CXSL2101085 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) New Drug Application 2021-05-20 Sichuan Baili Pharmaceutical Co Ltd view
CXSB2300035 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) Supplementary Application 2023-04-15 view
CXSL1900089 SI-B001双特异性抗体注射液 Izalontamab Injection Biological Products(1) New Drug Application 2019-08-17 四川百利药业有限责任公司 Sichuan Baili Pharmaceutical Co Ltd In Review 2019-08-16 view